Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Berit Bihlar Muld"'
BACKGROUND AND AIMS: The pharmacological treatment of individuals with attention deficit hyperactivity disorder (ADHD) and severe substance use disorder (SUD) is controversial, and few studies have examined the long-term psychosocial outcome of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbbad63e4abcc3519bce9b67879f63b0
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101505
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101505
Publikováno v:
BMC Psychiatry
Background Attention Deficit/Hyperactivity Disorder (ADHD) is associated with an increased risk of co-existing substance abuse. The Swedish legislation on compulsory healthcare can be applied to persons with severe substance abuse who can be treated